This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Signify Health Crecimiento futuro
Future controles de criterios 2/6
Información clave
11.8%
Tasa de crecimiento de los beneficios
12.7%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare | 17.2% |
| Tasa de crecimiento de los ingresos | 18.0% |
| Rentabilidad financiera futura | 13.4% |
| Cobertura de analistas | Low |
| Última actualización | 29 Mar 2023 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
CVS Health to offer bonds to finance purchase of Signify Health
Feb 13Signify Health and Prospect Medical come together to deliver coordinated, high-quality care
Jan 11Checking Signify Health Before The CVS Transaction
Dec 21Signify expands diagnostic offering with spirometry test for lung disease
Oct 18Signify Health jumps on report CVS in talks to acquire for about $8 billion
Sep 02Signify Health: Cathie Wood Now Selling
Aug 15CVS Health seeking purchase of Signify Health - WSJ
Aug 07Signify Health: ECS Wind Down Sheds Light On Compelling Valuation
Jul 21Signify Health Aims Higher With New CMS Terms
Mar 16Revisiting Signify Health
Jan 09Signify Health names Susan Yun as chief people officer
Jun 02Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2024 | 1,159 | 97 | 217 | 252 | 5 |
| 12/31/2023 | 982 | 96 | 217 | 206 | 3 |
| 12/31/2022 | 806 | 77 | 4 | 32 | N/A |
| 9/30/2022 | 784 | -518 | -3 | 30 | N/A |
| 6/30/2022 | 843 | -338 | -5 | 28 | N/A |
| 3/31/2022 | 810 | 32 | -20 | 11 | N/A |
| 12/31/2021 | 653 | 43 | 108 | 130 | N/A |
| 9/30/2021 | 786 | -3 | 100 | 126 | N/A |
| 6/30/2021 | 741 | -23 | 129 | 156 | N/A |
| 3/31/2021 | 659 | -23 | 97 | 126 | N/A |
| 12/31/2020 | 451 | -25 | 16 | 44 | N/A |
| 9/30/2020 | 550 | -8 | -11 | 26 | N/A |
| 12/31/2019 | 502 | N/A | 16 | 42 | N/A |
| 12/31/2018 | 338 | -29 | 23 | 36 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: SGFY's forecast earnings growth (11.8% per year) is above the savings rate (2.1%).
Beneficios vs. Mercado: SGFY's earnings (11.8% per year) are forecast to grow slower than the US market (15.4% per year).
Beneficios de alto crecimiento: SGFY's earnings are forecast to grow, but not significantly.
Ingresos vs. Mercado: SGFY's revenue (18% per year) is forecast to grow faster than the US market (7% per year).
Ingresos de alto crecimiento: SGFY's revenue (18% per year) is forecast to grow slower than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: SGFY's Return on Equity is forecast to be low in 3 years time (13.4%).